Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: Technoloy
No Comments
It’s clear that the digital therapeutics (DTx) industry has found new ways to harness the unique power of emerging technologies to improve health. The 2021…
By Pharmatrax Author
Category: Technoloy
No Comments
More than 7,000 rare diseases have been identified, but only 5% of those diseases have an approved treatment.1 While significant strides in conducting rare disease clinical…
By Pharmatrax Author
Category: Technoloy
No Comments
The demand for drugs to reduce the intensity of the damage caused by coronavirus infection is increasing at a rapid rate. AI is proving to…
By Pharmatrax Author
Category: Technoloy
No Comments
Almost every life science company — in particular, every pharmaceutical company — is under pressure to monitor the changes that are taking place in the…
By Pharmatrax Author
Category: Technoloy
No Comments
“One of the biggest challenges to medicine is the incorporation of information technology in our practices.” — Samuel Wilson Industries are changing at a faster…
By Pharmatrax Author
Category: Technoloy
No Comments
The use of mobile technology and artificial intelligence (AI) has increased in all fields, and healthcare is not an exception. The uptake of digital health…
By Pharmatrax Author
Category: Technoloy
No Comments
Novartis and Johnson & Johnson are among the companies best positioned to take advantage of future artificial intelligence disruption in the pharmaceuticals industry, our analysis…
By Pharmatrax Author
Category: Technoloy
No Comments
The World Health Organization announced a pandemic in April 2020. Artificial intelligence technologies have presented effective methods for accelerating research, monitoring spread of infection and…
By Pharmatrax Author
Category: Technoloy
No Comments
As the volume of data for drug discovery and development explodes, the ability of Pharma and medical practitioners to keep up and accelerate drug…
By Pharmatrax Author
Category: Technoloy
No Comments
Accenture recently surveyed 250 global pharmaceutical and biotechnology leaders to understand the state of digitalisation in biopharmaceutical R&D. It was found that some progress is…